These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21118801)

  • 21. Molecular insights into the regulatory landscape of PKC-related kinase-2 (PRK2/PKN2) using targeted small compounds.
    Gross LZF; Winkel AF; Galceran F; Schulze JO; Fröhner W; Cämmerer S; Zeuzem S; Engel M; Leroux AE; Biondi RM
    J Biol Chem; 2024 Aug; 300(8):107550. PubMed ID: 39002682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling.
    Thimmaiah KN; Easton JB; Germain GS; Morton CL; Kamath S; Buolamwini JK; Houghton PJ
    J Biol Chem; 2005 Sep; 280(36):31924-35. PubMed ID: 16009706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
    Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
    Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1.
    Xu X; Chen Y; Fu Q; Ni D; Zhang J; Li X; Lu S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):361-374. PubMed ID: 30734603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of the First Generation of Disulfide-Based Subtype-Selective and Potent Covalent Pyruvate Dehydrogenase Kinase 1 (PDK1) Inhibitors.
    Liu Y; Xie Z; Zhao D; Zhu J; Mao F; Tang S; Xu H; Luo C; Geng M; Huang M; Li J
    J Med Chem; 2017 Mar; 60(6):2227-2244. PubMed ID: 28230989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PDK1 master kinase is over-expressed in acute myeloid leukemia and promotes PKC-mediated survival of leukemic blasts.
    Zabkiewicz J; Pearn L; Hills RK; Morgan RG; Tonks A; Burnett AK; Darley RL
    Haematologica; 2014 May; 99(5):858-64. PubMed ID: 24334295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDK1 protein phosphorylation at Thr354 by murine protein serine-threonine kinase 38 contributes to negative regulation of PDK1 protein activity.
    Seong HA; Jung H; Manoharan R; Ha H
    J Biol Chem; 2012 Jun; 287(25):20811-22. PubMed ID: 22544756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell Invasion.
    Raimondi C; Calleja V; Ferro R; Fantin A; Riley AM; Potter BV; Brennan CH; Maffucci T; Larijani B; Falasca M
    Sci Rep; 2016 May; 6():26142. PubMed ID: 27199173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
    Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
    Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. For a PDK1 inhibitor, the substrate matters.
    Knight ZA
    Biochem J; 2011 Jan; 433(2):e1-2. PubMed ID: 21175429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of pyruvate dehydrogenase kinase 1 inhibitors with anti-osteosarcoma activity.
    Fang A; Luo H; Liu L; Fan H; Zhou Y; Yao Y; Zhang Y
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5450-5453. PubMed ID: 29150396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-throughput screening of novel pyruvate dehydrogenase kinases inhibitors and biological evaluation of their in vitro and in vivo antiproliferative activity.
    Wu DM; Wang YJ; Fan SH; Zhang ZF; Shan Q; Lu J; Chen GQ; Zheng YL
    Eur J Med Chem; 2019 Feb; 164():252-262. PubMed ID: 30597326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
    Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
    Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A patent update on PDK1 inhibitors (2015-present).
    Sestito S; Rapposelli S
    Expert Opin Ther Pat; 2019 Apr; 29(4):271-282. PubMed ID: 30897008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct structural mechanisms for inhibition of pyruvate dehydrogenase kinase isoforms by AZD7545, dichloroacetate, and radicicol.
    Kato M; Li J; Chuang JL; Chuang DT
    Structure; 2007 Aug; 15(8):992-1004. PubMed ID: 17683942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, crystal structures and anticancer activity of 4-substituted quinolines to target PDK1.
    Vennila KN; Sunny D; Madhuri S; Ciattini S; Chelazzi L; Elango KP
    Bioorg Chem; 2018 Dec; 81():184-190. PubMed ID: 30138906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting PDK1 in cancer.
    Raimondi C; Falasca M
    Curr Med Chem; 2011; 18(18):2763-9. PubMed ID: 21568903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
    Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
    J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells.
    Zhang W; Su J; Xu H; Yu S; Liu Y; Zhang Y; Sun L; Yue Y; Zhou X
    PLoS One; 2017; 12(6):e0179672. PubMed ID: 28617852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
    Kim HG; Tan L; Weisberg EL; Liu F; Canning P; Choi HG; Ezell SA; Wu H; Zhao Z; Wang J; Mandinova A; Griffin JD; Bullock AN; Liu Q; Lee SW; Gray NS
    ACS Chem Biol; 2013 Oct; 8(10):2145-50. PubMed ID: 23899692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.